Improving cancer treatment with PARP inhibitors by understanding how they work
Optimizing PARP inhibitor therapy through novel approaches to resolve the molecular mechanisms of response
This study is looking into how PARP inhibitors work to help treat certain cancers, especially for patients whose cancer cells have trouble fixing their DNA, to find out why some of these drugs work better than others and improve treatment options for you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10670095 on NIH RePORTER |
What this research studies
This research investigates how PARP inhibitors, which are used to treat certain cancers, function at a molecular level. It aims to uncover the mechanisms behind the effectiveness of these drugs, particularly in patients with DNA repair deficiencies. By analyzing various cancer cell lines, the study seeks to identify why some PARP inhibitors are more effective than others. This knowledge could lead to better treatment strategies for patients with malignancies that respond to PARP inhibition.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with cancers that have DNA repair deficiencies, such as those with BRCA mutations.
Not a fit: Patients whose cancers do not involve DNA repair deficiencies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer therapies that improve patient outcomes.
How similar studies have performed: Previous research has shown promise in understanding PARP inhibitors, but this study aims to explore novel aspects that have not been fully tested.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Dubach, John — Massachusetts General Hospital
- Study coordinator: Dubach, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.